I get where you're coming from, ST. A lot of us bought in because of the bold claims and the hope that IMU was onto something truly game-changing. “Obliterates and kills solid tumors” was a big part of the pitch, and that kind of statement builds serious expectations.
Four years in, down over 90 percent, and watching the SP slide to new lows, it’s hard not to feel let down. The frustration isn’t just about the price. It’s about the gap between what was promised and what’s been delivered.
If management genuinely believed in the company’s future and wanted to restore even a shred of confidence, they would be buying on-market right now. Actions speak louder than any ASX announcement or interview soundbite.
(20min delay)